Nurix Therapeutics, Inc.

NASDAQ:NRIX

19.83 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Operating Activities:
Net Income -48.956-44.546-41.518-41.956-36.982-24.277-40.733-46.717-45.709-45.401-42.533-37.702-28.835-26.382-24.275-19.914-18.5177.58-12.391-13.519-2.427-3.068-2.685
Depreciation & Amortization 4.1464.0913.8883.7573.3843.3333.183.0372.8862.6322.2534.0490.7450.6450.6430.6440.550.4950.4910.5490.5560.6030.646
Deferred Income Tax 000.93-8.8880000000000000000000
Stock Based Compensation 8.7548.8457.8228.0248.4458.7238.4818.2976.9886.7756.0714.8434.3133.9442.72.5361.1150.4740.1760.1670.1360.1050.102
Change In Working Capital -2.701-5.936-10.21353.88-14.783-5.298-18.618-1.922-10.5562.419-8.963-2.707-6.857-10.08628.763-3.89110.631-23.0252.6880.05538.11-0.3230.587
Accounts Receivables 0002-200608-2-60.475-1.6987.365-7.50000000
Change In Inventory 000-4.884.880000-803.82800000000000
Change In Accounts Payables 1.095-2.541-0.934.65-1.197-2.2390.4-0.899-0.7631.85-0.1030.862-1.3921.220.8990.632-1.1431.4470.2980.0430.4700
Other Working Capital -3.796-3.395-9.28352.11-16.466-3.059-19.018-7.023-9.7930.569-8.86-1.397-5.465-11.30627.864-4.52311.774-24.46752.390.01237.64-0.3230.587
Other Non Cash Items -3.4217.409-2.866.932-1.197-0.95-0.762-0.650.0830.6610.5420.6060.6620.3440.2220.1430.080.0420.008-1.819-0.003-10.658-8.332
Operating Cash Flow -42.177-39.705-41.95121.749-41.133-18.469-48.452-37.955-46.308-32.914-42.63-30.911-29.972-31.5358.053-20.482-6.141-14.42940.972-12.74836.372-13.341-9.682
Investing Activities:
Investments In Property Plant And Equipment -2.347-1.937-2.884-2.585-2.459-1.08-2.277-2.565-3.418-2.789-3.472-0.862-1.865-2.091-0.843-0.906-1.67-1.613-0.364-0.953-0.493-0.045-0.16
Acquisitions Net 38.3970-38.39788.49-25.234-44.911-18.345-57.57359.6581.9760000000000000
Purchases Of Investments -129.817-225.118-54.803-88.393-74.588-60.711-22.642-26.911-132.424-64.786-15.245-90.684-74.575-135.496-47.742-134.157-111.427-10.58-19.06-3.412000
Sales Maturities Of Investments 110.82595.98593.276.60599.822105.62240.98784.48472.76662.8158.74855.02364.20980.47746.19810.55.0169.85700400
Other Investing Activites -38.397-129.13338.397-88.4925.23444.91118.34557.573-59.658-1.97643.503-35.661-10.366-55.019-1.544-123.657-106.411-0.723-19.06-3.412410-0.439
Investing Cash Flow -21.339-131.0735.513-14.37322.77543.83116.06855.008-63.076-4.76540.031-36.523-12.231-57.11-2.387-124.563-108.081-2.336-19.424-4.3653.5079.955-0.599
Financing Activities:
Debt Repayment 00000000000000000000000
Common Stock Issued 41.872237.7671.6240.0071.7040.0250.028-0.13519.40.4321.488150.1571.552150.4711.36-1.154219.301000000
Common Stock Repurchased 0.015-0.015000000000000-0.00100000000
Dividends Paid 00000000000000000000000
Other Financing Activities 3.898237.7521.6240.0071.7040.0251.481-0.13596.0070.4321.4880.51.552150.4711.359-1.1261.119119.6840.0460.08-0.0070.0460.007
Financing Cash Flow 45.77237.7521.6244.9471.7040.0251.481-0.135115.4070.4321.4880.51.552150.4711.359-1.126220.42119.6840.0460.08-0.0070.0460.007
Other Information:
Effect Of Forex Changes On Cash 00000000000000000000000
Net Change In Cash -16.84566.977-4.81412.323-16.65425.387-30.90316.9186.023-37.247-1.111-66.934-40.65161.8267.025-146.171106.198102.91921.594-17.03339.872-3.34-10.274
Cash At End Of Period 99.945116.7949.81354.62743.20559.85934.47265.37548.45742.43479.68180.792147.726188.377126.551119.526265.697159.49956.5834.98652.01912.14715.487